Cargando…

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD

BACKGROUND: Increasing evidence shows that the ubiquitin–proteasome system has a crucial impact on lung adenocarcinoma. However, reliable prognostic signatures based on ubiquitination and immune traits have not yet been established. METHODS: Bioinformatics was performed to analyze the characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Yinggang, Jiang, Dongbo, Xu, Leidi, Sun, Yuanjie, Wu, Yingtong, Liu, Yang, Chang, Ning, Fan, Jiangjiang, Xi, Hangtian, Qiu, Dan, Ju, Qing, Pan, Jingyu, Zhang, Yong, Yang, Kun, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913715/ https://www.ncbi.nlm.nih.gov/pubmed/35281055 http://dx.doi.org/10.3389/fimmu.2022.846402

Ejemplares similares

Elevated ubiquitination contributes to protective immunity against severe SARS‐CoV‐2 infection
por: Che, Yinggang, et al.
Publicado: (2022)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
por: Xu, Leidi, et al.
Publicado: (2022)

HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression
por: Hu, Chenchen, et al.
Publicado: (2022)

Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
por: Zhang, Jieru, et al.
Publicado: (2020)

Assessment of Financial Toxicity Among Patients With Advanced Lung Cancer in Western China
por: Xu, Tianqi, et al.
Publicado: (2022)

METTL3-mediated m(6)A mRNA modification of FBXW7 suppresses lung adenocarcinoma
por: Wu, Yingtong, et al.
Publicado: (2021)

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
por: Fu, Linhai, et al.
Publicado: (2020)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
por: Li, Yadong, et al.
Publicado: (2023)

Pan-cancer landscape of CENPO and its underlying mechanism in LUAD
por: Shi, Tongdong, et al.
Publicado: (2023)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

A radiomics nomogram prediction for survival of patients with “driver gene-negative” lung adenocarcinomas (LUAD)
por: Guo, Qi-Kun, et al.
Publicado: (2023)

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
por: Ren, Wenjun, et al.
Publicado: (2022)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
por: Feng, Hai-Ming, et al.
Publicado: (2023)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
por: Shen, Zhenghai, et al.
Publicado: (2022)

Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
por: Zhang, Wentao, et al.
Publicado: (2022)

Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
por: Xing, Liangliang, et al.
Publicado: (2022)

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
por: Li, Yixin, et al.
Publicado: (2022)

Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD
por: Wang, Zixuan, et al.
Publicado: (2022)

RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation
por: Zhang, Lian, et al.
Publicado: (2023)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
por: Qiu, Yuan, et al.
Publicado: (2022)

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
por: Liu, Yang, et al.
Publicado: (2022)

Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients
por: Wu, Chen, et al.
Publicado: (2016)

SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
por: Zhang, Yanli, et al.
Publicado: (2022)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

CWHM-1008 Induces Apoptosis and Protective Autophagy through the Akt/mTOR Axis in LUAD Cells
por: Zhang, Jiao, et al.
Publicado: (2021)

DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target
por: Xu, Mingming, et al.
Publicado: (2023)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC)
por: Zhang, Lemeng, et al.
Publicado: (2020)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases
por: Zhang, Lili, et al.
Publicado: (2022)

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling
por: Li, Chaohao, et al.
Publicado: (2023)

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)
por: Lv, Fang, et al.
Publicado: (2021)

Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
por: Sun, Xinti, et al.
Publicado: (2022)

Advanced lung adenocarcinoma (LUAD) patient with EGFR mutations benefited from multiline combination targeted therapies after osimertinib (AZD9291) resistance: a case report
por: Chen, Jingyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tb1ij68jgkugcj2cdnse86i8d